Y-Intercept (HK)’s Guardant Health GH Stock Holding History

Y-Intercept (HK)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.88M	Buy	+52,547	New	+$5.71M	0.16%	144
2026 Q1	–	Sell	-18,715	Closed	-$1.91M	–	1740
2025 Q4	$1.91M	Sell	18,715 -57,580	-75%	-$5.15M	0.04%	648
2025 Q3	$4.77M	Buy	76,295 +30,526	+67%	+$1.66M	0.11%	224
2025 Q2	$2.38M	Buy	+45,769	New	+$2.04M	0.06%	521
2025 Q1	–	Sell	-13,799	Closed	-$422K	–	1350
2024 Q4	$422K	Buy	13,799 +1,863	+16%	+$52.4K	0.03%	804
2024 Q3	$274K	Sell	11,936 -38,937	-77%	-$1.1M	0.02%	1057
2024 Q2	$1.47M	Buy	50,873 +26,240	+107%	+$611K	0.08%	346
2024 Q1	$508K	Buy	+24,633	New	+$528K	0.04%	702
2023 Q3	–	Sell	-8,548	Closed	-$306K	–	1236
2023 Q2	$306K	Sell	8,548 -15,692	-65%	-$451K	0.03%	758
2023 Q1	$568K	Buy	+24,240	New	+$692K	0.07%	461

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Y-Intercept (HK)'s GH Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Guardant Health (GH) in Q2 2026: 52,547 shares worth $7.88M. The stake represents 0.16% of the portfolio and ranks #144 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in GH as recently as Q4 2025.

Y-Intercept (HK) first reported a position in GH in Q1 2023 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Y-Intercept (HK) held 52,547 shares of Guardant Health worth $7.88M as of Q2 2026.
Guardant Health was a new Y-Intercept (HK) position in Q2 2026.
Guardant Health made up 0.16% of Y-Intercept (HK)'s portfolio in Q2 2026, its #144 holding.
Y-Intercept (HK) first reported a position in Guardant Health in Q1 2023 and has held it in 10 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.